KIMBERLY KEEGAN: Open Payments
NPI 1033624903 · WETHERSFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,094 in 47 payments from 21 companies in 2025. Trend: 2023 $2,189 · 2024 $1,973 · 2025 $1,094
Food & beverage: $995Education: $99
| Company | Payments | Amount |
|---|---|---|
| ARRAY BIOPHARMA INC | 8 | $125 |
| Rigel Pharmaceuticals, Inc. | 4 | $110 |
| SEAGEN INC. | 1 | $99 |
| GENZYME CORPORATION | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 3 | $79 |
| Exelixis Inc. | 3 | $79 |
| Gilead Sciences, Inc. | 3 | $71 |
| ABBVIE INC. | 3 | $65 |
| Celgene Corporation | 3 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
Products named: TAVALISSE, LORBRENA, SARCLISA, CABOMETYX, Trodelvy, Fabhalta, OPDIVO, KEYTRUDA.
Industry payments across CT — which companies pay providers there.
